Scott Pomeroy, MD, PhD

Neurologist-in-Chief, Boston Children’s Hospital
Education
B.A. Miami University, 1975
Ph.D. University of Cincinnati, 1980
M.D. University of Cincinnati, 1982
 
Internship
Intern in Medicine, Boston Children’s Hospital, 1982-1983
 
Residency
Resident in Neurology, Barnes Hospital, 1984-1985
Resident in Child Neurology, St. Louis Children’s Hospital, 1985-1987
Junior Assistant Resident in Medicine, Boston Children’s Hospital, 1983-1984
 
Fellowship
Postdoctoral Fellow of Dale Purves, Department of Anatomy and Neurobiology, Washington University School of Medicine, 1987-1980
Scott L. Pomeroy is one of the world’s leading experts on pediatric brain cancer. His group was first to identify genetic markers that predict treatment response of medulloblastomas, the most common malignant brain tumor in children; he was among the first to apply genomic methods to studying childhood cancer. The results have been nothing short of revolutionary; brain tumors are now being classified by molecular features which define mechanisms of tumorigenesis and predict clinical outcome with much higher precision than clinical criteria. Through the Children’s Oncology Group, which unites 250 medical centers throughout North America, he leads an international effort to standardize tumor sample collection and to make genomic analysis a routine step in treatment planning for children with brain cancer.

He has won numerous awards for his research and clinical care of children with embryonal brain tumors including the Sidney Carter Award and the Daniel Drake Medal, and he was the first recipient of the Compassionate Caregiver Award of the Kenneth Schwartz Center, which honors a Massachusetts caregiver who displays extraordinary compassion in caring for patients and their families.

Dr. Pomeroy graduated from Miami University and was the first graduate of the M.D., Ph.D. program of the University of Cincinnati. He trained in pediatrics at Boston Children’s Hospital and in Child Neurology at St. Louis Children’s Hospital. In 1989, he won the Child Neurology Society Young Investigator Award for work done as a postdoctoral fellow with Dale Purves at Washington University. He currently is the Chair of the Department of Neurology and Neurologist-in-Chief of Boston Children's Hospital, the Bronson Crothers Professor of Neurology at Harvard Medical School, and the Director of the Eunice K. Shriver National Institutes of Child Health and Human Development funded Intellectual and Developmental Disabilities Research Center of Boston Children’s Hospital and Harvard Medical School.   

About Claritas

Claritas Genomics serves children affected with complex genetic disorders by providing timely and accurate results, resolving families’ long search for answers. By combining clinical expertise of the world’s best pediatric specialists with innovative platform solutions, Claritas is working to improve patient care and enable new discoveries. We are committed to the highest quality and accessibility of information and our interpretive services and unique approach to reporting set the standard for reliably and clearly communicating genetic information.

Now is the time to integrate genomics into clinical practice to inform, guide and improve medical treatment for kids around the world.